finance.yahoo.com Earnings
Avita Medical Targets Q4 2025 Cash Flow Breakeven as Revenue Growth Builds
Key Points Interested in Avita Medical Inc.? Here are five stocks we like better. Avita Medical raised its 2025 revenue guidance to $86 million–$89 million, citing sequential growth from $17.6 million to $21.7 million over recent quarters. The company is targeting cash flow breakeven in Q4 2025, supported by declining cash use, stable operating expenses and margins, and …